TrustNetwork & Supply Chain

Supporting international business matching, LSMIP propritizes "Speed" and "Accuracy" in out service.
Please be noted that contents are in English/Japanese, translated on a request basis from authors/members.
国際間のビジネス・マッチングを促進するため、LSMIPでは情報発信の迅速性・正確性を重視しております。
コンテンツは各言語(英語、日本語)でお読みいただけますが、必要に応じて翻訳する場合があります。
LSMIPSupply Chain
Curing the incurable (治らないをなくす)
Repertoire Genesis Inc. / レパトア・ジェネシス株式会社
  • Target Market
    Japan, USA, Other Countries
  • Business category
    Pharmaceutical, Biopharmaceutical
  • Business function
    Marketing > , Business consulting > Licensing
  • Author
    Eiichi Yamaguchi, Ph.D.
  • Outline of business
    Repertoire Genesis, Inc is a biotech company providing a next-generation TCR/BCR repertoire analysis with unbiased PCR and novel bioinformatics software originally developed by us. This technology makes it possible to accurately evaluate diversity and specify for evaluation of treatment effects by cancer immune cell therapy, bone marrow transplantation, or immune check point inhibitors. Our platform technologies can be used for development of promising advanced medical technologies such as TCR gene therapy, CAR-T therapy, antibody drug development, and immune cell therapy with neoantigen.
  • Now printing
  • Now printing
  • Now printing
Attachment
Contact info
Address
Saito Bioincubator 402,7-7-15 Saito-asagi, Ibaraki-shi, Osaka, 567-0085 Japan
Tel
+81-(0)3-4405-2685
Fax
+81-(0)3-4330-1286
Website
https://www.repertoire.co.jp/en/
Email
yamaguchi@repertoire.co.jp
Note
What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!

Article list

Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.
Accept